A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC

RecruitingOBSERVATIONAL

Enrollment

950

Participants

Timeline

Start Date

January 15, 2022

Primary Completion Date

July 31, 2024

Study Completion Date

June 15, 2025

Conditions

Non Small Cell Lung Cancer

Trial Locations (1)

RECRUITING

Beijing Cancer Prevention society, Beijing

All Listed Sponsors

collaborator

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

lead

Beijing Cancer Prevention & Treatment Society

OTHER